Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram Visit Frequency in MDD
NCT02480400Completed
- Sponsor
- Abarbanel Mental Health Center
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of escitalopram in major depressive disorder (MDD) (2 arms), sponsored by Abarbanel Mental Health Center. Primary endpoint: Sheehan Disability Scale at 8 weeks. Started Jun 2010; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02480400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480400.